Australia Adds New Mental Health Risks to Ozempic and Other Rapid Weight Loss Drugs
The government of Australia has added two new safety warnings about mental health and contraception for the popular GLP-1 agonist drugs like Ozempic designed to facilitate rapid weight loss. The Therapeutic Goods Administration (TGA), which regulates pharmaceutical products for Australia, issued the new safety warnings in December.1 Health professionals say that, while there is no […]
Guillain-Barré Syndrome Warning Added to Shingrix Vaccine in Australia
In February 2024, Australia’s Therapeutic Goods Administration (TGA), the country’s national regulatory authority for drugs and, initiated an investigation into a potential association between GSK plc’s Shingrix shingles vaccine, Guillain-Barré syndrome (GBS), which causes inflammation and damage to the nerves, that may include paralysis.1 The investigation was prompted by two reports of GBS following Shingrix […]
FDA Lab Uncovers Excess DNA Contamination in COVID-19 Vaccines
An explosive new study conducted within the U.S. Food and Drug Administration’s (FDA) own laboratory has revealed excessively high levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccine. Tests conducted at the FDA’s White Oak Campus in Maryland found that residual DNA levels exceeded regulatory safety limits by 6 to 470 times. The study was undertaken […]
Triathlete Who Suffered Torn Coronary Artery Days After COVID Shots Undergoes More Surgery
In mid-2021, triathlete and fitness instructor Ingi Doyle of Queensland, Australia received two doses of the Pfizer/BioNTech Comirnaty mRNA (messenger ribonucleic acid) COVID-19 biologic. The first shot on June 12, 2021 left her with a sore arm. After the second shot on July 4, she developed a severe adverse reaction that resulted in an aortic […]
Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]